From Scleroderma News (SclerodermaNews.com), August 17, 2016:

The Scleroderma Education Project (SclerodermaInfo.org) recently released guidelines for patients and doctors wishing to know more about therapeutic plasma exchange (TPE) as a treatment option for limited scleroderma. The guidelines are designed to facilitate data collection to support the launch of a randomized clinical trial, and follow the same setup as a recently published case report describing the successful 22-year repeat treatment of a patient with limited scleroderma.

By following the guidelines, a physician who decides to use TPE with a scleroderma patient will allow researchers to pool and analyze data from that individual trial. This way, scientists can determine if a randomized clinical trial should be performed.

See the full news story for more information: Scleroderma News: Guidelines for Therapeutic Plasma Exchange Individual Trials for Scleroderma.

The guidelines document itself can be downloaded here:

US Format: Suggested Guidelines for Individual Trials of Therapeutic Plasma Exchange for Treating Systemic Scleroderma.

A4 Format: Suggested Guidelines for Individual Trials of Therapeutic Plasma Exchange for Treating Systemic Scleroderma.

For more information on these suggested Guidelines, contact the author at eharris@sclerodermainfo.org.